| pubmed-article:8646345 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8646345 | lifeskim:mentions | umls-concept:C0278884 | lld:lifeskim |
| pubmed-article:8646345 | lifeskim:mentions | umls-concept:C0015385 | lld:lifeskim |
| pubmed-article:8646345 | lifeskim:mentions | umls-concept:C0025241 | lld:lifeskim |
| pubmed-article:8646345 | lifeskim:mentions | umls-concept:C0205341 | lld:lifeskim |
| pubmed-article:8646345 | lifeskim:mentions | umls-concept:C0396670 | lld:lifeskim |
| pubmed-article:8646345 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:8646345 | pubmed:dateCreated | 1996-7-24 | lld:pubmed |
| pubmed-article:8646345 | pubmed:abstractText | Melanoma recurring locoregionally after isolated limb perfusion (ILP) constitutes a therapeutic dilemma. Major amputation is a deterrent option for local control and palliation in these patients who have a rather poor prognosis. Little is known about the feasibility and efficacy of repeat ILP in these situations. | lld:pubmed |
| pubmed-article:8646345 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8646345 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8646345 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8646345 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8646345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8646345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8646345 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8646345 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:8646345 | pubmed:issn | 1072-7515 | lld:pubmed |
| pubmed-article:8646345 | pubmed:author | pubmed-author:KroonB BBB | lld:pubmed |
| pubmed-article:8646345 | pubmed:author | pubmed-author:EggermontA... | lld:pubmed |
| pubmed-article:8646345 | pubmed:author | pubmed-author:KlaaseJ MJM | lld:pubmed |
| pubmed-article:8646345 | pubmed:author | pubmed-author:VrouenraetsB... | lld:pubmed |
| pubmed-article:8646345 | pubmed:author | pubmed-author:van GeelB NBN | lld:pubmed |
| pubmed-article:8646345 | pubmed:author | pubmed-author:NiewegO EOE | lld:pubmed |
| pubmed-article:8646345 | pubmed:author | pubmed-author:KlopW MWM | lld:pubmed |
| pubmed-article:8646345 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8646345 | pubmed:volume | 182 | lld:pubmed |
| pubmed-article:8646345 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8646345 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8646345 | pubmed:pagination | 467-72 | lld:pubmed |
| pubmed-article:8646345 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:meshHeading | pubmed-meshheading:8646345-... | lld:pubmed |
| pubmed-article:8646345 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8646345 | pubmed:articleTitle | Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs. | lld:pubmed |
| pubmed-article:8646345 | pubmed:affiliation | Department of Surgery, The Netherlands Cancer Institute (Antoni van Leeuwenhoek ziekenhuis), Amsterdam, The Netherlands. | lld:pubmed |
| pubmed-article:8646345 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8646345 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8646345 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8646345 | lld:pubmed |
